Cancer Cell Metabolism Database ~~ Bioinformatics and Systems Medicine Laboratory ~~

Cancer Cell Metabolism Gene Database

Cancer Cell Metabolism Gene DB

Home

	Gene Summary
	Phenotypic Information (metabolism pathway, cancer, disease, phenome)
	Mutations : SVs, CNVs, SNVs
	Gene expression: GE, Protein, DEGE, CNV vs GE
	Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG
	Pharmacological Information: Drug-Gene Network
	Cross referenced IDs

Gene Summary for ALAS2

Basic gene info.	Gene symbol	ALAS2
	Gene name	5'-aminolevulinate synthase 2
	Synonyms	ALAS-E\|ALASE\|ANH1\|ASB\|XLDPP\|XLEPP\|XLSA
	Cytomap	UCSC genome browser: Xp11.21
	Genomic location	chrX :55035487-55057497
	Type of gene	protein-coding
	RefGenes	NM_000032.4, NM_001037967.3,NM_001037968.3,NM_001037969.2,
	Ensembl id	ENSG00000158578
	Description	5-aminolevulinate synthase, erythroid-specific, mitochondrial5-aminolevulinic acid synthase 2aminolevulinate, delta-, synthase 2delta-ALA synthase 2delta-ALA synthetasedelta-aminolevulinate synthase 2
	Modification date	20141219
dbXrefs	MIM : 301300
	HGNC : HGNC
	Ensembl : ENSG00000158578
	HPRD : 02356
	Vega : OTTHUMG00000021641
Protein	UniProt: go to UniProt's Cross Reference DB Table
Expression	CleanEX: HS_ALAS2
	BioGPS: 212
	Gene Expression Atlas: ENSG00000158578
	The Human Protein Atlas: ENSG00000158578
Pathway	NCI Pathway Interaction Database: ALAS2
	KEGG: ALAS2
	REACTOME: ALAS2
	ConsensusPathDB
	Pathway Commons: ALAS2
Metabolism	MetaCyc: ALAS2
	HUMANCyc: ALAS2
Regulation	Ensembl's Regulation: ENSG00000158578
	miRBase: chrX :55,035,487-55,057,497
	TargetScan: NM_000032
	cisRED: ENSG00000158578
Context	iHOP: ALAS2
	cancer metabolism search in PubMed: ALAS2
	UCL Cancer Institute: ALAS2
Assigned class in ccmGDB	C

Top

Phenotypic Information for ALAS2(metabolism pathway, cancer, disease, phenome)

Cancer Description
Cancer	CGAP: ALAS2
	Familial Cancer Database: ALAS2

* This gene is included in those cancer gene databases.


Oncogene ¹	Tumor Suppressor gene ²	Cancer Gene Census ³	CancerGenes ⁴	Network of Cancer Gene ⁵	Significant driver gene in	Therapeutic Vulnerabilities in Cancer¹

cf) number; DB name
1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long,
2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/,
3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html,
4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long,
5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php,
1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/

Metabolic Pathway Description
KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM REACTOME_METABOLISM_OF_PORPHYRINS

Others
OMIM
Orphanet
Disease	KEGG Disease: ALAS2
	MedGen: ALAS2 (Human Medical Genetics with Condition)
	ClinVar: ALAS2
Phenotype	MGI: ALAS2 (International Mouse Phenotyping Consortium)
Phenotype	PhenomicDB: ALAS2

Mutations for ALAS2

* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site.

Structural Variants in COSMIC : go to COSMIC mutation histogram

There's no structural variation information in COSMIC data for this gene.

Related fusion transcripts : go to Chitars2.0

* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows ALAS2 related fusion information.

ID	Head Gene						Tail Gene
Accession	Gene_a	qStart_a	qEnd_a	Chromosome_a	tStart_a	tEnd_a	Gene_a	qStart_a	qEnd_a	Chromosome_a	tStart_a	tEnd_a
AI207561	ALAS2	20	340	X	55035491	55039953	ALB	338	642	4	74285286	74286973
AF130113	CYB5B	1	854	16	69458507	69496744	ALAS2	847	1858	X	55035491	55044047

Other DBs for Structural Variants

Structural Variants in Ensembl: go to Ensembl Structural variation

Structural Variants in dbVar: go to dbVar

Top

Copy Number Variations in COSMIC : go to COSMIC mutation CNV/Expr

There's no copy number variation information in COSMIC data for this gene.

Top

SNV Counts per Each Loci in COSMIC data : go to COSMIC point mutation

: Non-synonymous mutation, : Synonymous mutation, Circle size denotes number of samples.
Maximum mutation count=4

Top

Somatic Mutation Counts per Tissue in COSMIC data

Stat. for Non-Synonymous SNVs (# total SNVs=54)	Stat. for Synonymous SNVs (# total SNVs=15)

Stat. for Deletions (# total SNVs=0)	Stat. for Insertions (# total SNVs=1)
There's no deleted snv.

Top

Top 10 SNVs Having the Most Samples in COSMIC data

* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID.

GRCh37 position	Mutation(aa)	Unique sampleID count
chr23:55046763-55046763	p.K271N	2
chr23:55042056-55042056	p.R375C	2
chr23:55042168-55042168	p.I337I	2
chr23:55047636-55047636	p.R163C	2
chr23:55040048-55040048	p.D491N	2
chr23:55042082-55042082	p.G366A	2
chr23:55047668-55047668	p.K152M	2
chr23:55039970-55039970	p.R517C	2
chr23:55044078-55044078	p.A282T	2
chr23:55042055-55042055	p.R375H	2

Top

SNV Counts per Each Loci in TCGA data

: non-synonymous mutation, : synonymous mutation, Circle size denotes number of samples.
maximum mutation count=2

Point Mutation/ Tissue ID	1	2	3	4	5	6	7	8	9	10	11	12	13	14	15	16	17	18	19	20
# sample	2	5	1	11			4		4			5		2	1		4	4		6
# mutation	2	5	1	10			4		4			5		2	1		4	4		10
nonsynonymous SNV		4	1	8			4		4					1	1		3	3		8
synonymous SNV	2	1		2								5		1			1	1		2

cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma])

Top

Top 10 SNVs Having the Most Samples in TCGA data

* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID.

Genomic Position	Mutation(aa)	Unique sampleID count
chrX:55039970	p.I300I,ALAS2	2
chrX:55042056	p.A207V,ALAS2	2
chrX:55046845	p.R338C,ALAS2	2
chrX:55042168	p.R480C,ALAS2	2
chrX:55043923	p.K459E,ALAS2	1
chrX:55039950	p.R126R,ALAS2	1
chrX:55047576	p.L457F,ALAS2	1
chrX:55041426	p.M296I,ALAS2	1
chrX:55051268	p.V110V	1
chrX:55043972	p.A446A,ALAS2	1

Other DBs for Point Mutations

Point Mutation Table of Ensembl: go to Ensembl variation table

Mutation of cBioPortal: go to cBioPortal's Cross-cancer alteration summary

Copy Number for ALAS2 in TCGA

* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene.

cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma]

Top

Gene Expression for ALAS2

Gene Expression in Cancer Cell-lines (CCLE)

* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data.

Differential Gene Expression in Primary Tumors (TCGA)

* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis.
(t test, adjusted p<0.05 (using Benjamini-Hochberg FDR))

Top

CNV vs Gene Expression Plot

* This plots show the correlation between CNV and gene expression.

: Open all plots for all cancer types

Top

Gene-Gene Network Information

Co-Expressed gene's network Plot

* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown.
Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene

: Open all plots for all cancer types


AHSP,ALAS2,ANO7,CA1,DMRTC1B,DUSP26,EPHA6, GSC,GYPB,HBA1,HBA2,HBB,HBD,HBG1, HBG2,HBM,SLC4A1,SPAG17,TSHZ1,ZADH2,ZCCHC13	AADACL3,AHSP,ALAS2,ARHGAP20,CA1,CLEC1B,DAND5, DRD1,GFI1B,HBA1,HBB,HBD,IFIT1B,KRTAP21-2, LCE6A,LIMS3-LOC440895,LOC283914,MSC,PCDHAC1,SLC4A1,SSC4D

ADIPOQ,ALAS2,ANGPTL5,AQP7,CD300LG,CD36,EPB42, HBA2,HBB,LBP,LEP,LIPE,MRAP,PCOLCE2, PLIN4,PTCHD3,SCGB3A2,SGCG,SLC4A1,TAAR1,TTTY9B	ALAS2,LINC00596,SCP2D1,CLDN6,CNGB1,GAL,HBA1, HELT,LOC157627,ANKRD30BL,ODF4,PAPL,PFN3,SLC4A1, SNORA64,SNORA74A,SNORD94,SPATA21,tAKR,TRIM67,USP26

Co-Expressed gene's Protein-protein interaction Network Plot

: Open all plots for all cancer types

Top

Interacting Genes (from Pathway Commons)

: Open all interacting genes' information including KEGG pathway for all interacting genes from DAVID

Top

Pharmacological Information for ALAS2

Cross-referenced pharmacological DB IDs from Uniprot

DB Category

DB Name

DB's ID and Url link

Drug-Gene Interaction Network

* Gene Centered Interaction Network.

* Drug Centered Interaction Network.

DrugBank ID	Target Name	Drug Groups	Generic Name	Drug Centered Network	Drug Structure
DB00145	aminolevulinate, delta-, synthase 2	approved; nutraceutical	Glycine
DB00114	aminolevulinate, delta-, synthase 2	nutraceutical	Pyridoxal Phosphate

Top

Cross referenced IDs for ALAS2

* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section

: Open all cross reference information